Michael Lofgren
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
17
Citations
352
Est. group size
—
Recurring co-author estimate
Active years
22
Publishing since 2004
Typically publishes in teams of ~11 · 0% small-team papers (≤3 authors) · across 6 venues
- Membrane-bound IL-15 co-expression powers a potent and persistent CD70-targeted TRuC T-cell therapy
Frontiers in Immunology · 2025
- Functional enhancement of mesothelin-targeted TRuC-T cells by a PD1-CD28 chimeric switch receptor
Cancer Immunology Immunotherapy · 2023
- Functional enhancement of mesothelin-targeted TRuC-T cells by a PD1-CD28 chimeric switch receptor
Research Square · 2023
- 219 The functional activity of gavo-cel TRuC-T cells is not impaired by soluble mesothelin
Regular and Young Investigator Award Abstracts · 2022
- Abstract 1528: Discovery and preclinical characterization of fratricide-resistant TRuC T-cells targeting CD70
Cancer Research · 2021
- Abstract 893: A chimeric PD1-CD28 switch receptor enhances the activity of TRuC-T cells
Cancer Research · 2020
- Structure of human POFUT1, its requirement in ligand-independent oncogenic Notch signaling, and functional effects of Dowling-Degos mutations
Glycobiology · 2017
- Cancer Research×2
- Glycobiology×1
- Cancer Immunology Immunotherapy×1
- Journal of Biological Chemistry×1
- Frontiers in Immunology×1
- Markus Ruetz
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Joseph A. Krzycki
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- E. Neil G. Marsh
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Amardeep Kumar
Biochemistry, Genetics and Molecular Biology · Indiana University
- Ruisheng Jiang
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile